Clinical Trial Update: Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety, tolerability, and pharmacokinetics of TIMP-GLIA in subjects with Celiac Disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• TIMP-GLIA

Snippet

Sponsor: Takeda | Conditions: Celiac Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-06-05